Renata Jaskula‐Sztul

Neuroendocrine Tumor‐Targeted Upconversion Nanoparticle‐Based Micelles for Simultaneous NIR‐Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging

Guojun Chen, Renata Jaskula‐Sztul, Corinne R. Esquibel et al. · Advanced Functional Materials · 2017 · 173 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Valproic Acid Activates Notch-1 Signaling and Regulates the Neuroendocrine Phenotype in Carcinoid Cancer Cells

David Yü Greenblatt, Abram Vaccaro, Renata Jaskula‐Sztul et al. · The Oncologist · 2007 · 146 citations

Medicine, Cancer Biology, Pharmacology +16

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma

Marzena Gajęcka, Małgorzata Rydzanicz, Renata Jaskula‐Sztul et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2005 · 122 citations

Medicine, Genetics, Oncology +12

Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy

Yuling Xiao, Renata Jaskula‐Sztul, Alireza Javadi et al. · Nanoscale · 2012 · 114 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth

Xiao-Min Yu, Renata Jaskula‐Sztul, Kamal Ahmed et al. · Molecular Cancer Therapeutics · 2013 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16